Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Founded in 2018, Kyverna Therapeutics is backed by investors that include Vida Ventures and Westlake Village BioPartners and is headquartered in Berkeley, California.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Life Science, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
